Biobytes
PrivateLast Round
Early Funding
Jun 4, 2026
Total Funding Raised
$1.85M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Biobytes operates in Healthcare & Life Sciences and is based in Chuncheon. Its latest recorded funding round was an Early Funding round in June 2026.
Biobytes is a health technology company that develops AI-powered platforms for sarcopenia risk assessment, biomarker discovery, and muscle health management.
Sector
Healthcare & Life Sciences
Verticals
Medical AI, Drug Discovery, Precision Medicine, Healthcare Analytics, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Biobytes Comparables
Compare Biobytes with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Biomdcare Corporation | 82% | |
| IMOON HEALTHCARE Co., Ltd. | 71% | |
| ClariPi Inc. | 68% |
For institutional investors. Book with your work email.
Biobytes Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 4, 2026 | ||||
| Seed | Nov 15, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Biobytes Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KOTEC | Early Funding |
| Gangwon Creative Economy Innovation Center | Seed |
| CNT Tech | Seed |
| Sopoong Ventures | Seed |
| Newborn Ventures | Early Funding |
| Kingsley Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors increased 110% MoM.
- Jun 4, 2026
$1.4M raised from Newborn Ventures and KOTEC.
For institutional investors. Book with your work email.
Biobytes Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Biobytes's valuation, stock price, and market status.
Is Biobytes a public or private company?
Biobytes is a private company.
What is the current stock price of Biobytes?
Biobytes is a private company, so its shares have no public market price. Caplight tracks Biobytes's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Biobytes worth (valuation)?
Valuation information for Biobytes is not publicly available.
Can I buy Biobytes stock?
Biobytes shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Biobytes's last funding round?
Biobytes's most recent funding round was Early Funding on June 4, 2026.
Who are the main investors in Biobytes?
Key investors in Biobytes include Kingsley Ventures.
Will Biobytes IPO soon?
No public IPO plans have been announced for Biobytes.
How can I track Biobytes secondary market activity?
Caplight tracks bids, offers, and trades in Biobytes's shares on secondary markets.